Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.

Satlin MJ, Soave R, Racanelli AC, Shore TB, van Besien K, Jenkins SG, Walsh TJ.

Leuk Lymphoma. 2014 Dec;55(12):2858-65. doi: 10.3109/10428194.2014.896007.

2.

Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.

Vydra J, Shanley RM, George I, Ustun C, Smith AR, Weisdorf DJ, Young JA.

Clin Infect Dis. 2012 Sep;55(6):764-70. doi: 10.1093/cid/cis550.

3.

Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.

Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E, Pettit NN.

Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120.

PMID:
23911080
4.

Vancomycin-resistant enterococci infection: not just for the transplanted.

Rosko AE, Corriveau M, Suwantarat N, Arfons L, Treasure M, Parker P, Jacobs M, Fu P, Salata R, Lazarus HM.

Leuk Lymphoma. 2014 Jun;55(6):1320-5. doi: 10.3109/10428194.2013.842983.

PMID:
24024476
5.

The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.

Ford CD, Lopansri BK, Gazdik MA, Snow GL, Webb BJ, Konopa KL, Petersen FB.

Transpl Infect Dis. 2015 Oct;17(5):688-94. doi: 10.1111/tid.12433.

PMID:
26256692
6.

Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?

Dubberke ER, Hollands JM, Georgantopoulos P, Augustin K, DiPersio JF, Mundy LM, Khoury HJ.

Bone Marrow Transplant. 2006 Dec;38(12):813-9.

PMID:
17057724
7.

Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.

Mikulska M, Del Bono V, Prinapori R, Boni L, Raiola AM, Gualandi F, Van Lint MT, Dominietto A, Lamparelli T, Cappellano P, Bacigalupo A, Viscoli C.

Transpl Infect Dis. 2010 Dec;12(6):505-12. doi: 10.1111/j.1399-3062.2010.00544.x.

PMID:
20636482
8.

The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA, Papanicolaou G.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1576-81. doi: 10.1016/j.bbmt.2010.05.008.

9.

Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.

Cho SY, Lee DG, Choi SM, Kwon JC, Kim SH, Choi JK, Park SH, Park YJ, Choi JH, Yoo JH.

BMC Infect Dis. 2013 Oct 29;13:504. doi: 10.1186/1471-2334-13-504.

10.

Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.

Avery R, Kalaycio M, Pohlman B, Sobecks R, Kuczkowski E, Andresen S, Mossad S, Shamp J, Curtis J, Kosar J, Sands K, Serafin M, Bolwell B.

Bone Marrow Transplant. 2005 Mar;35(5):497-9.

PMID:
15640812
11.

Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.

Kapur D, Dorsky D, Feingold JM, Bona RD, Edwards RL, Aslanzadeh J, Tutschka PJ, Bilgrami S.

Bone Marrow Transplant. 2000 Jan;25(2):147-52.

12.

Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.

Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M.

Transpl Infect Dis. 2014 Feb;16(1):106-14. doi: 10.1111/tid.12175.

PMID:
24372809
13.

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.

Seo SK, Xiao K, Huang YT, Jongwutiwes U, Chung D, Maloy M, Giralt S, Barker JN, Jakubowski AA, Papanicolaou GA.

J Infect. 2014 Oct;69(4):341-51. doi: 10.1016/j.jinf.2014.06.004.

14.

Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.

Gedik H, Yıldırmak T, Simşek F, Kantürk A, Arıca D, Aydın D, Yokuş O, Demirel N, Arabacı C.

J Infect Dev Ctries. 2014 Sep 12;8(9):1113-8. doi: 10.3855/jidc.4451.

15.

Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, Young JW, Kiehn TE, Zuccotti G.

Biol Blood Marrow Transplant. 2007 May;13(5):615-21.

16.

[Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].

Marron A, Carratalà J, Ayats J, Fernández de Sevilla A, Domínguez MA, Liñares J, Gudiol F.

Med Clin (Barc). 1998 Dec 12;111(20):761-4. Spanish.

PMID:
9922964
17.

Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.

Graber CJ, de Almeida KN, Atkinson JC, Javaheri D, Fukuda CD, Gill VJ, Barrett AJ, Bennett JE.

Bone Marrow Transplant. 2001 Mar;27(5):537-42.

18.

Vancomycin-resistant enterococcal bacteremia pharmacotherapy.

Patel R, Gallagher JC.

Ann Pharmacother. 2015 Jan;49(1):69-85. doi: 10.1177/1060028014556879. Review.

PMID:
25352037
19.

Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.

Chou CH, Lee NY, Lee HC, Chang CM, Lee CC, Ko WC.

J Microbiol Immunol Infect. 2012 Jun;45(3):221-7. doi: 10.1016/j.jmii.2011.11.005.

Items per page

Supplemental Content

Support Center